Cite
HARVARD Citation
Beinse, G. et al. (2020). Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments. International journal of gynecological cancer. 30 (5), pp. 640-647. [Online].